Medfarm at the top of grants list
Researchers at Medfarm amount to almost half of the total projects funded by grants from the Child Diabetes Foundation.
This year, the Child Diabetes Foundation is distributing SEK 19.4 million for research projects aimed at preventing, curing, or alleviating type 1 diabetes. In total, there are 26 different projects, and of these, twelve are led by researchers at Medfarm.
The Child Diabetes Foundation is the largest funder of research dedicated to preventing, alleviating, and curing type 1 diabetes. Every year, the foundation allocates several million SEK to outstanding research projects.
.jpg)
Per-Ola Carlsson, Professor of Medical Cell Biology at the Department of Medical Cell Biology, received the largest grant for his project “Treating and Preventing Type 1 Diabetes with Mesenchymal Stem Cells”.
This year, no fewer than 12 researchers at Uppsala University and the Disciplinary Domain of Medicine and Pharmacy have been granted funds for their research projects. This means that almost half of all funded projects are led by researchers from the Faculties of Medicine and Pharmacy.
In total, funds amounting to SEK 9,817,888 have been allocated to research projects led by Medfarm researchers.
The largest grant has been awarded to Per-Ola Carlsson, Professor of Medical Cell Biology at the Department of Medical Cell Biology, and his project “Treating and Preventing Type 1 Diabetes with Mesenchymal Stem Cells.”
“The support from the Child Diabetes Foundation enables our research on cell therapies to halt immune attacks against insulin-producing beta cells. Ultimately, it provides us with the conditions to find a curative therapy for type 1 diabetes,” says Per-Ola Carlsson in a statement to the Child Diabetes Foundation.
Among the highest grants are also Olle Korsgren, Professor of Transplantation Immunology at the Department of Immunology, Genetics, and Pathology, and Nils Welsh, Professor of Medical Cell Biology at the Department of Medical Cell Biology.
Robin Widing
Grants to Medfarm from the Child Diabetes Foundation
Per-Ola Carlsson
Treating and Preventing Type 1 Diabetes with Mesenchymal Stem Cells
Nils Welsh
Strategies to reduce intracellular adenosine levels as a means to achieve beta-cell survival in Type 1 diabetes
Olle Korsgren
Application of newly developed PET imaging modalities, digital biopsies, to unravel the immunopathological processes in Type 1 Diabetes
Olof Eriksson
MIDAS study - Macrophage and Neutrophil Imaging in Diabetes – År 3
Joey Lau Börjesson
Exploring strategies for preventing the formation of cytotoxic IAPP amyloid in human stem cell-derived islet-like cell clusters
Xuan Wang
Studies of the role of extracellular vesicles in the interaction between beta cells and immune cells for enhanced diagnosis and treatment of type 1 diabetes
Bryndis Birnir
How physiological molecules guide release of inflammatory molecules from T cells
Daniel Espes
In depth studies of the islet vasculature
Jin Cen
Strategies for long-term monitoring of the transplanted insulinproducing islet-like cell clusters derived from human pluripotent stem cells
Gustaf Christoffersson
Advancing Research on Neuro-Immune Interactions in T1D: A Proposal for Novel Methodologies
Louise Granlund
Elucidating the etiology of type 1 diabetes with the aim of developing novel intervention strategies
Robin Lindsay
Linking T cell behaviour and gene expression profiles to determine tolerance mechanisms to halt progression of type 1 diabetes